Muraglitazar
CAS: 331741-94-7
Ref. TM-T21587
| 1mg | 272.00 € | ||
| 5mg | 668.00 € | ||
| 10mg | 920.00 € | ||
| 25mg | 1,388.00 € | ||
| 50mg | 1,846.00 € | ||
| 100mg | 2,564.00 € |
Estimated delivery in United States, on Thursday 23 May 2024
Product Information
Name:
Muraglitazar
Synonyms:
- Pargluva, BMS-298585
- Bms-298585
- Glycine, N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]-
- N-(4-Methoxyphenoxycarbonyl)-N-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]benzyl]glycine
- N-[(4-Methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine
- N-[(4-methoxyphenoxy)carbonyl]-N-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzyl}glycine
- Pargluva
CAS:
Description:
Muraglitazar (BMS-298585) is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia. Muraglitazar shows potent activity in vitro at human PPARα and PPARγ with EC50 of 320 nM and 110 nM respectively.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
516.54
Formula:
C29H28N2O7
Purity:
99.31%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T21587 Muraglitazar
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
